You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Accelerated phase MPN

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Accelerated Phase MPN, Blast Phase MPN Trial (zelavespib)

Withdrawn
  • Accelerated Phase MPN
  • Blast Phase MPN
  • (no location specified)
Nov 4, 2022

MDS, Myeloproliferative Tumor, Anemia Trial in Tampa (Luspatercept)

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Feb 16, 2023

Myelofibrosis (PMF), Post Essential Thrombocythemia Myelofibrosis (ET-MF), Post Polycythemia Vera Related Myelofibrosis (PV-MF)

Not yet recruiting
  • Myelofibrosis (PMF)
  • +2 more
  • New York, New York
    Ruttenberg Treatment Center
Apr 18, 2023

MDS/MPN Trial in Nashville (ASTX727, Itacitinib)

Recruiting
  • MDS/MPN
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Jun 20, 2022

Accelerated/Blast-phase Myeloproliferative Tumor, Chronic-phase Myelofibrosis, IDH2 Mutation Trial in Canada, United States

Recruiting
  • Accelerated/Blast-phase Myeloproliferative Neoplasm
  • +2 more
  • Scottsdale, Arizona
  • +10 more
May 9, 2022

Lung Cancer Trial in Palo Alto (Hypofractionated accelerated radiation therapy)

Not yet recruiting
  • Lung Cancer
  • Hypofractionated accelerated radiation therapy
  • Palo Alto, California
    Stanford University
Oct 11, 2023

Acute Myeloid Leukemia, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Seattle (Decitabine, Ruxolitinib,

Recruiting
  • Acute Myeloid Leukemia
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 18, 2022

Chronic Myeloid Leukemia in Myeloid Blast Crisis, Chronic Myeloid Leukaemia Transformation, Chronic Myeloid Leukemia -

Recruiting
  • Chronic Myeloid Leukemia in Myeloid Blast Crisis
  • +3 more
  • based decitabine and olverembatinib（HQP1351)chemotherapy
  • Guanzhou, China
    Department of Hematology, Nanfang Hospital, Southern Medical Uni
Dec 6, 2022

Mild Cognitive Impairment, Depression Trial in Charleston (Accelerated iTBS, Sham Comparator)

Not yet recruiting
  • Mild Cognitive Impairment
  • Depression
  • Accelerated iTBS
  • Sham Comparator
  • Charleston, South Carolina
    Medical University of South Carolina
Aug 7, 2023

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 31, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Boston (Venetoclax, Obinutuzumab, Rituximab)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Dec 5, 2022

ph Negative Myeloproliferative Neoplasms: Impact on Outcome and

Recruiting
  • Myeloproliferative Disease
  • Inflammatory Markers
    • Bari, Italy
    • +10 more
    Oct 21, 2022

    Lung Cancer, Solid Tumor, Gastric Cancer Trial in Denmark, United States (Pemigatinib, Gemcitabine + Cisplatin, Pembrolizumab)

    Completed
    • Lung Cancer
    • +10 more
    • Birmingham, Alabama
    • +19 more
    Jan 4, 2022

    Early-stage Glottic Larynx Cancer Trial in Dallas (CyberKnife Accelerated Hemilarynx Stereotactic Radiotherapy)

    Completed
    • Early-stage Glottic Larynx Cancer
    • CyberKnife Accelerated Hemilarynx Stereotactic Radiotherapy
    • Dallas, Texas
      University Of Texas Southwestern Medical Center
    Jun 27, 2022

    Acute Myeloid Leukemia, Myeloproliferative Tumor, Myelodysplastic/Myeloproliferative Tumor Trial in Canada, United States

    Recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • Birmingham, Alabama
    • +9 more
    Aug 30, 2021

    Myelofibrosis, Essential Thrombocythemia, MPN Trial in New York (Peptide-based vaccine, Poly ICLC)

    Not yet recruiting
    • Myelofibrosis
    • +2 more
    • Peptide-based vaccine
    • Poly ICLC
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Jun 7, 2022

    MDS, Myeloproliferative Tumor Trial in United States (Azacitidine Subcutaneous Injection or Intravenous Infusion, Pevonedistat

    Active, not recruiting
    • Myelodysplastic Syndromes
    • Myeloproliferative Neoplasm
    • Azacitidine Subcutaneous Injection or Intravenous Infusion
    • +2 more
    • Miami, Florida
    • +4 more
    Jun 20, 2022

    Myelodysplastic/Myeloproliferative Tumor With Ring Sideroblasts and Thrombocytosis, Myelodysplastic/Myeloproliferative Tumor,

    Recruiting
    • Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis
    • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 6, 2023

    Lymphedema Trial in New York (Intensity-modulated radiation therapy (IMRT))

    Active, not recruiting
    Has Results
    • Lymphedema
    • Intensity-modulated radiation therapy (IMRT)
    • New York, New York
      Laura and Issac Perlmutter Cancer Center
    Jul 7, 2022

    Esophageal Cancer Trial in Shantou (Radiotherapy with simultaneous modulated accelerated boost, Standard dose radiotherapy, PF)

    Recruiting
    • Esophageal Cancer
    • Radiotherapy with simultaneous modulated accelerated boost
    • +2 more
    • Shantou, Guangdong, China
      Cancer Hospital, Shantou University Medical College
    Dec 27, 2021

    Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Myelodysplastic Syndrome With Excess Blasts Trial (Biospecimen

    Not yet recruiting
    • Chronic Myelomonocytic Leukemia
    • +3 more
    • Biospecimen Collection
    • +3 more
    • (no location specified)
    Oct 27, 2022

    MDS, Myeloproliferative Tumors, Myelofibrosis Trial (Jaktinib, azacitidine)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • (no location specified)
    Nov 29, 2021

    Chemo-induced Alopecia Trial in Caba (hair lotion)

    Recruiting
    • Chemotherapy-induced Alopecia
    • hair lotion
    • Caba, Buenos Aires, Argentina
      Instituto Roffo
    Aug 29, 2023

    Breast Tumors, Tumor Recurrence, Local Trial in Beijing (Accelerated Partial Breast Irradiation)

    Recruiting
    • Breast Neoplasms
    • Neoplasm Recurrence, Local
    • Accelerated Partial Breast Irradiation
    • Beijing, Beijing, China
      National Cancer Center/Cancer Hospital, Chinese Academy of Medic
    Jan 6, 2022

    Myeloproliferative Tumor Trial in New York (Vactosertib)

    Recruiting
    • Myeloproliferative Neoplasm
    • New York, New York
      Weill Medical College of Cornell University
    Dec 20, 2021